Definium Therapeutics, Inc. (DFTX) — Financial Flexibility Index
Definium Therapeutics, Inc. (DFTX) has a Financial Flexibility Index of -0.39x as of December 2025. Free cash flow of $-41.89 Million (operating CF $-41.89 Million minus capex $0.00) represents 0% of total liabilities ($107.77 Million). Check how strategically is Definium Therapeutics, Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Definium Therapeutics, Inc. Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Definium Therapeutics, Inc. across 11 annual periods. See Definium Therapeutics, Inc. (DFTX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Definium Therapeutics, Inc. (2015–2025)
Year-by-year free cash flow to debt coverage for Definium Therapeutics, Inc.. For the full company profile including market capitalisation, see Definium Therapeutics, Inc. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.22x | $-131.56 Million | $-131.56 Million | $107.77 Million | ▲ +6.4% |
| 2024 | -1.30x | $-79.13 Million | $-79.13 Million | $60.70 Million | ▲ +6.0% |
| 2023 | -1.39x | $-64.36 Million | $-64.36 Million | $46.41 Million | ▲ +47.2% |
| 2022 | -2.63x | $-50.14 Million | $-50.14 Million | $19.08 Million | ▲ +29.2% |
| 2021 | -3.71x | $-45.82 Million | $-45.82 Million | $12.34 Million | ▲ +11.1% |
| 2020 | -4.18x | $-23.60 Million | $-23.60 Million | $5.65 Million | ▼ -888.7% |
| 2019 | 0.53x | $105.34K | $-208.12K | $198.96K | ▼ -98.6% |
| 2018 | 39.05x | $321.39K | $-722.45K | $8.23K | ▲ +111.8% |
| 2017 | 18.44x | $1.48 Million | $-665.98K | $80.44K | ▲ +40104.7% |
| 2016 | 0.05x | $3.46K | $-26.64K | $75.47K | ▲ +100.7% |
| 2015 | -6.22x | $-46.56K | $-46.56K | $7.49K | — |